Skip to main content

Advertisement

SpringerLink
Log in

Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?

  • Editorial
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Girgrah N, Liu P, Collier J, Blendis L, Wong F. Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis. Gut 2000;46:114–20.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Wong F, Sniderman K, Blendis L. The renal sympathetic and renin-angiotensin response to lower body negative pressure in well-compensated cirrhosis. Gastroenterology 1998;115:397–405.

    Article  PubMed  CAS  Google Scholar 

  • Wong F, Massie D, Hsu P, Dudley F. Renal response to a saline load in well-compensated alcoholic cirrhosis. Hepatology 1994;20:873–81.

    Article  PubMed  CAS  Google Scholar 

  • Arroyo V, Jimenez W. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem. J Hepatol 2000;32:157–70.

    Article  PubMed  CAS  Google Scholar 

  • Newby DE, Jalan R, Masumori S, Hayes PC, Boon NA, Webb DJ. Peripheral vascular tone in patients with cirrhosis: role of the renin-angiotensin and sympathetic nervous systems. Cardiovasc Res 1998;38:221–8.

    Article  PubMed  CAS  Google Scholar 

  • Epstein M. Renin-angiotensin system in liver disease. In: Epstein M, editor. The kidney in liver disease. Philadelphia: Hanley and Belfus}; 1996. p. 267–89.

  • van Vliet AA, Hackeng WH, Donker AJ, Meuwissen SG. Efficacy of low-dose captopril in addition to furosemide and spironolactone in patients with decompensated liver disease during blunted diuresis. J Hepatol 1992;15:40–7.

    Article  PubMed  CAS  Google Scholar 

  • Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, et al. Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 1990;252:719–25.

    PubMed  CAS  Google Scholar 

  • Sanyal AJ. Angiotensin receptor blockade and portal hypertension: paradise gained and paradise lost. Gastroenterology 2001; 121:487–90.

    Article  PubMed  CAS  Google Scholar 

  • Yang YY, Lin HC, Lee WC, Hou MC, Lee FY, Chang FY, Lee SD. One-week losartan administration increases sodium excretion in cirrhotic patients with and without ascites.J Gastroenterol 2002;37:194–9.

    Article  PubMed  CAS  Google Scholar 

  • Schneider AW, Kalk JF, Klein CP. Effect of losartan, an angiotensin II receptor antagonist, on portal pressure in cirrhosis. Hepatology 1999;29:334–9.

    Article  PubMed  CAS  Google Scholar 

  • Gonzalez-Abraldes J, Albillos A, Banares R, Del Arbol LR, Moitinho E, Rodriguez C, et al.Randomized comparison of longterm losartan versus propranolol in lowering portal pressure in cirrhosis.Gastroenterology 2001;121:382–8.

    Article  PubMed  CAS  Google Scholar 

  • Tabibiazar R, Jamali AH, Rockson SG. Formulating clinical strategies for angiotensin antagonism: a review of preclinical and clinical studies. Am J Med 2001;110:471–80.

    Article  PubMed  CAS  Google Scholar 

  • Sellars L, Shore AC, Mott V, Wilkinson R. The reninangiotensin- aldosterone system in decompensated cirrhosis: its activity in relation to sodium balance. Q J Med 1985;56:485–96.

    PubMed  CAS  Google Scholar 

  • Gentile S, Angelico M, Chiappini MG, Peruzzi G, Vulterini S. Clinical and hormonal conditions associated with sodium retention in cirrhotic patients with ascites. Evaluation by univariate and multivariate analyses. Dig Dis Sci 1987;32:569–76.

    CAS  Google Scholar 

  • Aliaga L, Zozaya JM, Quiroga J, Richter JA, Prieto J. Renal hemodynamics and the renin-angiotensin system in cirrhosis. Rev Esp Fisiol 1989;45(suppl):371–5.

    PubMed  Google Scholar 

  • Asbert M, Jimenez W, Gaya J, Gines P, Arroyo V, Rivera F, Rodes J. Assessment of the renin-angiotensin system in cirrhotic patients. Comparison between plasma renin activity and direct measurement of immunoreactive renin. J Hepatol 1992;15:179–83.

    Article  PubMed  CAS  Google Scholar 

  • Jalan R, Hayes PC. Sodium handling in patients with well compensated cirrhosis is dependent on the severity of liver disease and portal pressure. Gut 2000;46:527–33.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  • Gines P, Fernandez-Esparrach G, Arroyo V, Rodes J. Pathogenesis of ascites in cirrhosis. Semin Liver Dis 1997;17:175–89.

    Article  PubMed  CAS  Google Scholar 

  • Fukui H, Uemura M, Tsujii T. Pathophysiology and treatment of cirrhotic ascites. In: Yamanaka M, Toda G, Tanaka T, editors. Progress in hepatology, vol. 4. Liver cirrhosis update. Elsevier: Amsterdam; 1998. p. 63–76.

    Google Scholar 

  • Schrier RW, Arroyo V, Bernardi M, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1998;8:1151–7.

    Article  Google Scholar 

  • Garcia-Tsao G. Angiotensin II receptor antagonists in the pharmacological therapy of portal hypertension: a caution. Gastroenterology, 1999;117:740–2.

    Google Scholar 

  • Schepke M, Werner E, Biecker E, Schiedermaier P, Heller J, Neef M, et al. Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension. Gastroenterology 2001;121:389–95.

    Article  PubMed  CAS  Google Scholar 

  • Helmy A, Jalan R, Newby DE, Hayes PC, Webb D J. Role of angiotensin II in regulation of basal and sympathetically stimulated vascular tone in early and advanced cirrhosis. Gastroenterology 2000;118:565–72.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Third Department of Internal Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8521, Japan

    Hiroshi Fukui M.D., Ph.D.

Authors
  1. Hiroshi Fukui M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fukui, H. Does angiotensin II type 1 receptor blockade offer a clinical advantage to cirrhotics with ascites?. J Gastroenterol 37, 235–237 (2002). https://doi.org/10.1007/s005350200029

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005350200029

Search

Navigation